ConductScience.org, home
An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes
API referenceFor AI assistants

Trial · NCT00229658

Adverse events58

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 58

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousAngina pectorisCardiac disordersType 1 Diabetes1766
seriousAngina pectorisCardiac disordersType 2 Diabetes0531
seriousAngina unstableCardiac disordersType 1 Diabetes1766
seriousAngina unstableCardiac disordersType 2 Diabetes0531
seriousAtrioventricular block completeCardiac disordersType 1 Diabetes0766
seriousAtrioventricular block completeCardiac disordersType 2 Diabetes1531
seriousCardiac failure congestiveCardiac disordersType 1 Diabetes1766
seriousCardiac failure congestiveCardiac disordersType 2 Diabetes1531
seriousCoronary artery diseaseCardiac disordersType 1 Diabetes0766
seriousCoronary artery diseaseCardiac disordersType 2 Diabetes1531
seriousMyocardial infarctionCardiac disordersType 1 Diabetes0766
seriousMyocardial infarctionCardiac disordersType 2 Diabetes1531
seriousPancreatitisGastrointestinal disordersType 1 Diabetes1766
seriousPancreatitisGastrointestinal disordersType 2 Diabetes0531
seriousChest painGeneral disordersType 1 Diabetes0766
seriousChest painGeneral disordersType 2 Diabetes1531
seriousHernia obstructiveGeneral disordersType 1 Diabetes0766
seriousHernia obstructiveGeneral disordersType 2 Diabetes1531
seriousCholecystitis acuteHepatobiliary disordersType 1 Diabetes1766
seriousCholecystitis acuteHepatobiliary disordersType 2 Diabetes0531

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00229658/events

API referenceFor AI assistants